secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001193125-25-178092
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assembly Bio prices $175M equity financing; net proceeds ~$167M
---------------------------------------------------------------

- Underwritten offering: 5.6M shares + 1.04M pre-funded warrants at $19.60/unit; net ~$122M.
- Gilead purchases 2.3M shares + warrants in private placement at same price; net ~$45M.
- Class A warrants exercisable at $21.60, expire 5 years from issuance or 30 days after Phase 2 enrollment announcement.
- Class B warrants exercisable after Nov 15, 2026 until Dec 31, 2026; terminate early if $75M non-dilutive collaboration capital received.
- Proceeds for general corporate purposes; closings on August 11, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000119312525178092/0001193125-25-178092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000119312525178092/d442009d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-178092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer